Propel Bio Management, LLC Portfolio Holdings
Propel Bio Management, LLC
- $154 Billion
- Q2 2024
Propel Bio Management, LLC has filed its 13F form on August 12, 2024 for Q2 2024 where it was disclosed a total value porftolio of $154 Billion distributed in 25 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Applied Therapeutics Inc. with a value of $30.7B, Plains Gp Holdings LP with a value of $25.8B, T Scan Therapeutics, Inc. with a value of $12.2B, Madrigal Pharmaceuticals, Inc. with a value of $12.1B, and Achieve Life Sciences Inc with a value of $11.5B.
Examining the 13F form we can see an decrease of $17.6B in the current position value, from $172B to 154B.
Propel Bio Management, LLC is based out at Los Angeles, CA
Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.